assessing response to hydroxyurea treatment
Published 6 years ago • 3K plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
7:17
patients with intolerance to hydroxyurea
-
6:37
case 2: a pv patient with intolerance to hydroxyurea
-
4:36
treatment for pv: moving beyond hydroxyurea
-
5:43
moving beyond hydroxyurea for polycythemia vera
-
4:54
case 1: a patient with disease progression on hydroxyurea
-
5:14
case 1: a pv patient with disease progression on hydroxyurea
-
9:19
debate: should jak inhibitors use be limited to hydroxyurea-resistant/intolerant pv patients? - no
-
17:31
how do you treat pv patients that fail hydroxyurea (hu)?
-
6:49
the efficacy and safety of hydroxyurea therapy vs.switching to ruxolitinib in pv patients
-
0:57
moving beyond hydroxyurea in polycythemia vera
-
5:11
case 1: treatment response rates & the role of ir
-
19:03
assessment of novel treatment options for patients with pv
-
4:29
laboratory monitoring for polycythemia vera
-
4:26
controlling hematocrit in polycythemia vera
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
3:32
rationale for switching polycythemia therapy
-
17:54
current therapy options and clinical outcomes analysis in patients with pv
-
6:51
resistance to targeted-tki treatment in patients with cml
-
1:33
dr. okada discusses immunotherapy response assessment in neuro-oncology